RECORD // Company

Cencora, Inc.

Formerly: AMERISOURCEBERGEN CORP; AMERISOURCE BERGEN CORP

Built 2026-11-22T00:03:58Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (6 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (5)
  • AB FINCO LTD · legal entity in this company's GLEIF ownership tree (LEI 549300YJISWIXGC1P024)
  • ALLIANCE HEALTHCARE S.R.O · legal entity in this company's GLEIF ownership tree (LEI 2138004VQV5C7P592376)
  • BEACHCOURSE LIMITED · legal entity in this company's GLEIF ownership tree (LEI 213800WOL4GT5SUXW338)
  • CENCORA, INC. · legal entity in this company's GLEIF ownership tree (LEI AI8GXW8LG5WK7E9UD086)
  • OTC DIRECT LIMITED · legal entity in this company's GLEIF ownership tree (LEI 213800JSSYG63REZ1E28)
SEC EDGAR (1)
Records under a former name (12)

The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.

Matched by name only, not merged (13)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

9 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-06-30, filed 2026-08-05 · accession 0001140859-26-000034

ItemValuePeriodFormFiledAccessionReport
Revenue$84,754,837,0003 months ended 2026-06-3010-Q2026-08-050001140859-26-0000342026-11-22 00:03 UTCReport an error
Net income (loss)$763,518,0003 months ended 2026-06-3010-Q2026-08-050001140859-26-0000342026-11-22 00:03 UTCReport an error
Cash and cash equivalents$2,815,291,000at 2026-06-3010-Q2026-08-050001140859-26-0000342026-11-22 00:03 UTCReport an error
Debt due in the next 12 months (from an earlier report)$115,200,000at 2025-09-3010-K2025-11-250001140859-25-0001312026-11-22 00:03 UTCReport an error
Debt due in year 2 (from an earlier report)$24,900,000at 2025-09-3010-K2025-11-250001140859-25-0001312026-11-22 00:03 UTCReport an error
Debt due in year 3 (from an earlier report)$2,700,000,000at 2025-09-3010-K2025-11-250001140859-25-0001312026-11-22 00:03 UTCReport an error
Debt due in year 4 (from an earlier report)$8,700,000at 2025-09-3010-K2025-11-250001140859-25-0001312026-11-22 00:03 UTCReport an error
Debt due in year 5 (from an earlier report)$1,100,000,000at 2025-09-3010-K2025-11-250001140859-25-0001312026-11-22 00:03 UTCReport an error
Debt due after year 5 (from an earlier report)$3,800,000,000at 2025-09-3010-K2025-11-250001140859-25-0001312026-11-22 00:03 UTCReport an error

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001140859
Ticker
COR
EIN
233079390
CUSIP
03073E105
Record ID
sx:sec:0001140859

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

34 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-13SEC EDGAR company profile2026-11-22 00:03 UTCReport an error
SIC industry5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries2026-11-13SEC EDGAR company profile2026-11-22 00:03 UTCReport an error
State of incorporationDE2026-11-13SEC EDGAR company profile2026-11-22 00:03 UTCReport an error
Fiscal year end (MMDD)09302026-11-13SEC EDGAR company profile2026-11-22 00:03 UTCReport an error
Business address1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 194282026-11-13SEC EDGAR company profile2026-11-22 00:03 UTCReport an error
ExchangesNYSE2026-11-13SEC EDGAR company profile2026-11-22 00:03 UTCReport an error
Revenue (fiscal year ended 2025-09-30)$321,332,819,0002025-09-3010-K, XBRL Revenues2026-11-22 00:03 UTCReport an error
Net income (loss) (fiscal year ended 2025-09-30)$1,554,169,0002025-09-3010-K, XBRL NetIncomeLoss2026-11-22 00:03 UTCReport an error
Total assets (at 2025-09-30)$76,590,112,0002025-09-3010-K, XBRL Assets2026-11-22 00:03 UTCReport an error
Stockholders' equity (at 2025-09-30)$1,508,019,0002025-09-3010-K, XBRL StockholdersEquity2026-11-22 00:03 UTCReport an error
Cash and cash equivalents (at 2025-09-30)$4,356,138,0002025-09-3010-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:03 UTCReport an error
Operating cash flow (fiscal year ended 2025-09-30)$3,875,120,0002025-09-3010-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:03 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-09-30)$667,981,0002025-09-3010-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:03 UTCReport an error
Long-term debt (at 2025-09-30)$7,660,773,0002025-09-3010-K, XBRL LongTermDebt2026-11-22 00:03 UTCReport an error
Operating lease liabilities (at 2025-09-30)$1,670,403,0002025-09-3010-K, XBRL OperatingLeaseLiability2026-11-22 00:03 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-04)New Reporting Structure In order to advance its growth priorities, Cencora recently completed a restructuring of its operating model intended to strengthen execution and improve visibility. As a result of this restructuring, the Company has reorganized all business components within the U.S. Healthcare Solutions and International Healthcare Solutions reportable segments. Beginning in the first quarter of fiscal 2027, the Company’s reporting structure will be comprised of Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other. The Pharmaceutical Distribution and Services reportable segment will consist of U.S. and international wholesale…2026-11-04SEC EDGAR 8-K 0001140859-26-000040 (text as filed, excerpt)2026-11-22 00:03 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-04)Earnings Release for the Fiscal Quarter and Year Ended September 30, 2026 On November 4, 2026, Cencora, Inc. (the “Company”) issued a news release announcing the Company’s earnings for the fiscal quarter and year ended September 30, 2026. A copy of the news release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information in this Current Report, including the exhibit attached hereto as Exhibit 99.1 and the information under Item 7.01 below, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the…2026-11-04SEC EDGAR 8-K 0001140859-26-000038 (text as filed, excerpt)2026-11-22 00:03 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-04)On November 4, 2026, the Company is conducting a conference call and webcast scheduled to be held at 8:30 a.m. Eastern time regarding its results for the fiscal quarter and year ended September 30, 2026 and related matters. A link to the conference call and slides prepared for the conference call are available on the Company's website at investor.cencora.com.2026-11-04SEC EDGAR 8-K 0001140859-26-000038 (text as filed, excerpt)2026-11-22 00:03 UTCReport an error
8-K Item 2.02, Results of Operations and Financial (filed 2026-10-21)Condition. On October 21, 2026, Cencora, Inc., a Delaware corporation (the “Company”), announced updated fiscal year 2026 financial expectations and the transaction described in Item 7.01 below, pursuant to the news release described in Item 7.01 below. A copy of the news release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The updated financial expectations included in the news release described in Item 7.01 below are based on information available to Company management as of the date of the news release. In addition, because the Company’s financial closing procedures for the full-year 2026 are not yet complete, the Company’s actual results may change as a…2026-10-21SEC EDGAR 8-K 0001104659-26-117576 (text as filed, excerpt)2026-11-22 00:03 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-10-21)On October 21, 2026, the Company issued a news release announcing that it has entered into an Agreement and Plan of Merger, dated as of October 20, 2026, by and among the Company, Dolphins Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”) and American Oncology Network, Inc., a Delaware corporation (“AON”), pursuant to which, upon the terms and subject to the conditions set forth therein, Merger Sub will merge with and into AON (the “Merger”), with AON surviving the Merger as a wholly-owned subsidiary of the Company. A copy of the news release is attached hereto as Exhibit 99.1 and incorporated herein by reference. Cautionary Note Regarding…2026-10-21SEC EDGAR 8-K 0001104659-26-117576 (text as filed, excerpt)2026-11-22 00:03 UTCReport an error
8-K Item 5.02, Departure of Directors or Certain Officers; Election (filed 2026-09-25)of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Director Appointment On September 24, 2026, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Robert E. Sanchez to serve on the Board (the “Appointment”), effective October 1, 2026 (the “Effective Date”). In connection with the Appointment, the Board increased from ten to eleven members in accordance with the Company’s Amended and Restated Bylaws. Mr. Sanchez will receive the same benefits and compensation as the other non-employee directors on the Board pursuant to the Company’s Compensation Policy for Non-Employee Directors, as described on pages 40 to 41 of the…2026-09-25SEC EDGAR 8-K 0001104659-26-110624 (text as filed, excerpt)2026-11-22 00:03 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-09-25)On September 25, 2026, the Company issued a news release announcing the Appointment. A copy of the news release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information provided herein shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such…2026-09-25SEC EDGAR 8-K 0001104659-26-110624 (text as filed, excerpt)2026-11-22 00:03 UTCReport an error
Plan (pension, plan no. 010)CENCORA EMPLOYEE INVESTMENT PLAN: 21,858 participants, assets $2,443,121,3032025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:03 UTCReport an error
Plan (welfare, plan no. 650)CENCORA, INC. GROUP HEALTH AND WELFARE PLAN: 15,004 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:03 UTCReport an error
Largest institutional holder #1 (13F as filed): BlackRock, Inc.$5,154,136,2412026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error
Largest institutional holder #2 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$3,502,993,2902026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error
Largest institutional holder #3 (13F as filed): VANGUARD PORTFOLIO MANAGEMENT LLC$2,719,934,7132026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error
Largest institutional holder #4 (13F as filed): STATE STREET CORP$2,624,351,7092026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error
Largest institutional holder #5 (13F as filed): JPMORGAN CHASE & CO$1,674,031,5842026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error
Largest institutional holder #6 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$1,537,937,5722026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error
Largest institutional holder #7 (13F as filed): Boston Partners$1,380,607,6142026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error
Largest institutional holder #8 (13F as filed): WELLINGTON MANAGEMENT GROUP LLP$1,290,321,1672026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error
Largest institutional holder #9 (13F as filed): FMR LLC$1,166,548,8082026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error
Largest institutional holder #10 (13F as filed): BANK OF AMERICA CORP /DE/$1,056,625,0822026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:03 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.